BCAP31 and hepatocellular carcinoma: In addition, we treated the mice received HCC cells with self-developed BAP31 monoclonal antibody, which not only inhibited subcutaneous tumor growth, but also reduced tumor metastasis in mice injected HCC cells in the tail vein, indicating that BAP31 may be involved in the invasion and migration of HCC.